Cite

HARVARD Citation

    Bartelink, I. et al. (2019). Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle. Clinical pharmacology & therapeutics. 106 (1), pp. 148-163. [Online]. 
  
Back to record